End-of-day quote
OTC Markets
23:00:00 25/04/2024 BST
|
5-day change
|
1st Jan Change
|
0.0005
USD
|
-94.44%
|
|
-66.67%
|
-99.92%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
480.7
|
825.3
|
1,557
|
7,388
|
3,457
|
451.8
|
Enterprise Value (EV)
1 |
454.6
|
777.2
|
1,484
|
7,484
|
4,135
|
1,656
|
P/E ratio
|
-3.42
x
|
-5.71
x
|
-6.06
x
|
-9.34
x
|
-8.5
x
|
-0.14
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
7.05
x
|
5.59
x
|
7.18
x
|
26.4
x
|
7.51
x
|
0.88
x
|
EV / Revenue
|
6.66
x
|
5.26
x
|
6.84
x
|
26.8
x
|
8.98
x
|
3.21
x
|
EV / EBITDA
|
-4.16
x
|
-7.41
x
|
-8.28
x
|
-19.5
x
|
-5.96
x
|
-2.86
x
|
EV / FCF
|
-9.96
x
|
-12.1
x
|
-62.6
x
|
-572
x
|
-13.7
x
|
-7.01
x
|
FCF Yield
|
-10%
|
-8.3%
|
-1.6%
|
-0.17%
|
-7.32%
|
-14.3%
|
Price to Book
|
4
x
|
5.16
x
|
4.2
x
|
3.93
x
|
1.17
x
|
4.49
x
|
Nbr of stocks (in thousands)
|
52,945
|
74,617
|
96,522
|
176,700
|
226,371
|
242,896
|
Reference price
2 |
9.080
|
11.06
|
16.13
|
41.81
|
15.27
|
1.860
|
Announcement Date
|
06/03/18
|
28/02/19
|
02/03/20
|
26/02/21
|
01/03/22
|
28/02/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
68.22
|
147.7
|
216.8
|
279.6
|
460.4
|
516.3
|
EBITDA
1 |
-109.4
|
-104.9
|
-179.3
|
-384
|
-694.1
|
-578.3
|
EBIT
1 |
-117.6
|
-118.4
|
-195.5
|
-423
|
-774.5
|
-714.2
|
Operating Margin
|
-172.4%
|
-80.17%
|
-90.18%
|
-151.3%
|
-168.22%
|
-138.34%
|
Earnings before Tax (EBT)
1 |
-125.2
|
-132.2
|
-260.4
|
-714.3
|
-415.9
|
-3,151
|
Net income
1 |
-123.4
|
-129.4
|
-242
|
-602.2
|
-379
|
-3,106
|
Net margin
|
-180.85%
|
-87.58%
|
-111.6%
|
-215.37%
|
-82.31%
|
-601.64%
|
EPS
2 |
-2.653
|
-1.938
|
-2.663
|
-4.474
|
-1.797
|
-13.18
|
Free Cash Flow
1 |
-45.63
|
-64.49
|
-23.7
|
-13.09
|
-302.9
|
-236.1
|
FCF margin
|
-66.88%
|
-43.66%
|
-10.93%
|
-4.68%
|
-65.77%
|
-45.73%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
06/03/18
|
28/02/19
|
02/03/20
|
26/02/21
|
01/03/22
|
28/02/23
|
Fiscal Period: December |
2021 Q2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
---|
Net sales
1 |
116.3
|
114.4
|
126.1
|
123.7
|
136.6
|
133.5
|
122.5
|
117.4
|
120.5
|
121.2
|
EBITDA
1 |
-115.5
|
-159.4
|
-146
|
-136.7
|
-108.2
|
-48.29
|
-39.71
|
-41.54
|
-63.98
|
-26.78
|
EBIT
1 |
-134.1
|
-181
|
-169.6
|
-163.8
|
-145.4
|
-88.77
|
-77.06
|
-76.5
|
-97.68
|
-58.52
|
Operating Margin
|
-115.34%
|
-158.2%
|
-134.51%
|
-132.41%
|
-106.41%
|
-66.48%
|
-62.93%
|
-65.18%
|
-81.04%
|
-48.27%
|
Earnings before Tax (EBT)
1 |
-145.5
|
-204
|
-212.8
|
-216.8
|
-2,527
|
-302.2
|
-105.2
|
-193.1
|
-207.4
|
-948.3
|
Net income
1 |
-129
|
-198.2
|
-205.1
|
-181.9
|
-2,523
|
-301.2
|
-99.82
|
-192.2
|
-206.5
|
-942.1
|
Net margin
|
-110.88%
|
-173.24%
|
-162.64%
|
-147.03%
|
-1,847.04%
|
-225.52%
|
-81.51%
|
-163.76%
|
-171.33%
|
-777.05%
|
EPS
2 |
-0.6400
|
-0.9100
|
-0.9000
|
-0.8000
|
-10.87
|
-1.270
|
-0.4100
|
-0.7700
|
-0.7800
|
-3.420
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
03/08/21
|
08/11/21
|
24/02/22
|
03/05/22
|
09/08/22
|
08/11/22
|
28/02/23
|
09/05/23
|
08/08/23
|
08/11/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
96.2
|
679
|
1,204
|
Net Cash position
1 |
26.1
|
48.1
|
73
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-0.2504
x
|
-0.9779
x
|
-2.082
x
|
Free Cash Flow
1 |
-45.6
|
-64.5
|
-23.7
|
-13.1
|
-303
|
-236
|
ROE (net income / shareholders' equity)
|
-112%
|
-91.2%
|
-89.4%
|
-51.1%
|
-15.3%
|
-202%
|
ROA (Net income/ Total Assets)
|
-43%
|
-30%
|
-23%
|
-12.6%
|
-11.6%
|
-13%
|
Assets
1 |
286.8
|
431.8
|
1,054
|
4,797
|
3,269
|
23,916
|
Book Value Per Share
2 |
2.270
|
2.140
|
3.840
|
10.60
|
13.10
|
0.4100
|
Cash Flow per Share
2 |
0.2200
|
1.490
|
1.530
|
0.6700
|
4.050
|
1.050
|
Capex
1 |
6.68
|
5.97
|
20
|
22.9
|
54.7
|
53.3
|
Capex / Sales
|
9.78%
|
4.04%
|
9.25%
|
8.18%
|
11.88%
|
10.33%
|
Announcement Date
|
06/03/18
|
28/02/19
|
02/03/20
|
26/02/21
|
01/03/22
|
28/02/23
|
|
1st Jan change
|
Capi.
|
---|
| -99.92% | 143K | | -19.97% | 10.82B | | +47.54% | 3.25B | | -32.87% | 2.11B | | -14.15% | 2.08B | | -25.81% | 1.48B | | +19.31% | 1.02B | | -2.62% | 733M | | -30.96% | 391M | | -43.37% | 383M |
Bio Diagnostics & Testing
|